EDISON, N.J., Jan. 22, 2025 — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, announced the […]
This new collaboration was driven by the successful fast tracking of joint projects in Germany and Italy follows the recently signed three-way clean energy cooperation agreement between Italy, Albania, and the United Arab Emirates Neve Yarak, Israel, […]
MIAMI, FL AND LONDON, UK / December 24, 2024 / MGO Global Inc. (NASDAQ:MGOL), a digitally-native, lifestyle brand portfolio company, (“MGO,” “MGO Global” or the “Company”), today announced the closing of its previously announced public […]
BROOMFIELD, CO – January 17, 2025 – Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the […]
– 10-Minute PSA Test for Early Detection of Prostate Specific Antigen (PSA), an Early Warning Sign of Prostate Cancer – Prostate Cancer: The Second Most Common Cancer in Men Globally IRVINE, Calif., Jan. 16, 2025 […]
Safeguarding Advanced Powertrain Technology and Boaters’ Data from Third-Party Substitution MONTREAL, QC // January 14, 2025 / Vision Marine Technologies Inc. (the “Company,” “Vision Marine,” “we,” “us,” “our”) (NASDAQ:VMAR) is pleased to announce the filing […]
Strategic Transaction Introduces Game-Changing Energy and IoT Innovations, Setting the Stage for Long-Term Shareholder Value Michael McLaren appointed Chairman of Safe & Green MIAMI, FL, Jan. 14, 2025 — Safe & Green Holdings Corp. (NASDAQ: […]
Castellum Announces the Award of a $3.2 million Contract to its Specialty Systems, Inc. Subsidiary VIENNA, Va., Jan. 14, 2025 — Castellum, Inc. (NYSE: CTM) (“Castellum”), a cybersecurity, electronic warfare, and software engineering services company […]
Company to also display ADAM Robot in North Hall, Booth 8549 LAS VEGAS, Dec. 19, 2024 — Richtech Robotics Inc. (NASDAQ: RR) (“Richtech Robotics” or the “Company”), a Nevada-based provider of AI-driven service robots, announces […]
Measuring brain age with EEG and BNA™ could lead to a proactive and scalable approach to early screening for Alzheimer’s patients KENMORE, N.Y., Jan. 14, 2025 — Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: […]
ONTARIO, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) — Nature’s Miracle Holding, Inc. (NASDAQ: NMHI) (“Nature’s Miracle”), a growing agriculture technology company providing equipment and services to growers, announced that it entered into a Securities Purchase […]
New data from proof-of-concept study provides roadmap for treatment of ovarian cancer CAMBRIDGE, Mass., Jan. 14, 2025 — Eterna Therapeutics (NASDAQ: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today […]
Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma Marlborough, Massachusetts– January 13, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA […]
Initial order placed with Company’s distributor at contracted price and represents operational implementation through VA Federal Supply Schedule (FSS) Contract NEWTOWN, Pa., Dec. 23, 2024 — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (“Helius” or the “Company”), […]
– Updated data for IMM-1-104 in combination with modified gemcitabine/nab-paclitaxel (mGnP) in first-line pancreatic cancer patients show favorable overall response rate (ORR = 43%) and disease control rate (DCR = 86%); planning for pivotal trial […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
